Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Endoxifen by Jina Pharmaceuticals for Bipolar I Disorder: Likelihood of Approval
Endoxifen is under clinical development by Jina Pharmaceuticals and currently in Phase III for Bipolar I Disorder. According to GlobalData,...
Endoxifen by Atossa Therapeutics for Ductal Carcinoma In Situ: Likelihood of Approval
Endoxifen is under clinical development by Atossa Therapeutics and currently in Phase II for Ductal Carcinoma In Situ. According to...
Risk adjusted net present value: What is the current valuation of Atossa Therapeutics's Endoxifen?
"Endoxifen is a small molecule commercialized by Atossa Therapeutics, with a leading Phase II program in Ductal Carcinoma In Situ....
Risk adjusted net present value: What is the current valuation of Atossa Therapeutics's Endoxifen?
Endoxifen is a small molecule commercialized by Atossa Therapeutics, with a leading Phase II program in Ductal Carcinoma In Situ....